After WHO granted Covaxin a limited Emergency Use Listing, many institutions and hedge funds are likely to sell or short OCGN stock. More
Articles
Digital World Acquisition Corp Stock Is Worth Watching, But Wait for Another Big Sell-Off
The issue? It's probably not one worthy of a $10 billion valuation. Or perhaps a $5 billion one, for that matter. As more information about TMTG and Truth Social becomes known? It'll be easier to assess a fair price for it today. Until then, wait for the recent bubble in DWAC stock to deflate. More
CVS Health Needs a Managed Care Strategy That Can Catch United Healthcare
CVS Health bought Aetna believing its pharmacy network could deliver managed care at lower costs. Now former Aetna executive Karen Lynch must prove it to stoke CVS stock. More
Lucid Stock Has a Frightening Valuation on Only a Little Good News
EVs are starting to ramp up now from both the upstarts and the big automakers. It's an exciting time, and LCID stock offers its own thrills. More
Use Logic, Not Clichés When Analyzing Your Next Move With Ethereum
While the rise in Ethereum is incredibly enticing, it pays for prospective ETH-USD investors to step aside and take a breather. More
Sundial Growers Stock Is a Good Buy If You Can Manage Your Expectations
Sundial Growers announces Q3 2021 results Nov. 11. With Alcanna acquisition in hand, will it be a day to remember or forget for SNDL stock? More
Can Pinterest TV Help the Stock Regain Its Mojo?
Pinterest's decline in monthly average users is troubling, but its latest venture could provide some needed support for PINS stock. More
